Two Genetically Distinct Plasmodium knowlesi Duffy Binding Protein Alpha Region II (PkDBPαII) Haplotypes Demonstrate Higher Binding Level to Fy(a+b+) Erythrocytes than Fy(a+b--) Erythrocytes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: American Society of Tropical Medicine and Hygiene Country of Publication: United States NLM ID: 0370507 Publication Model: Print Cited Medium: Internet ISSN: 1476-1645 (Electronic) Linking ISSN: 00029637 NLM ISO Abbreviation: Am J Trop Med Hyg Subsets: MEDLINE
    • Publication Information:
      Publication: Northbrook, IL : American Society of Tropical Medicine and Hygiene
      Original Publication: Baltimore.
    • Subject Terms:
    • Abstract:
      Invasion of human erythrocytes by merozoites of Plasmodium knowlesi involves interaction between the P. knowlesi Duffy binding protein alpha region II (PkDBPαII) and Duffy antigen receptor for chemokines (DARCs) on the erythrocytes. Information is scarce on the binding level of PkDBPαII to different Duffy antigens, Fy a and Fy b . This study aims to measure the binding level of two genetically distinct PkDBPαII haplotypes to Fy(a+b-) and Fy(a+b+) human erythrocytes using erythrocyte-binding assay. The binding level of PkDBPαII of Peninsular Malaysian and Malaysian Borneon haplotypes to erythrocytes was determined by counting the number of rosettes formed in the assay. Overall, the Peninsular Malaysian haplotype displayed higher binding activity than the Malaysian Borneon haplotype. Both haplotypes exhibit the same preference to Fy(a+b+) compared with Fy(a+b-), hence justifying the vital role of Fy b in the binding to PkDBPαII. Further studies are needed to investigate the P. knowlesi susceptibility on individuals with different Duffy blood groups.
    • References:
      Parasit Vectors. 2014 Apr 03;7:161. (PMID: 24693997)
      J Exp Med. 1994 Aug 1;180(2):497-506. (PMID: 8046329)
      Parasit Vectors. 2018 Sep 26;11(1):527. (PMID: 30257710)
      J Receptor Ligand Channel Res. 2016;9:1-11. (PMID: 28943755)
      Malar J. 2015 Feb 21;14:91. (PMID: 25890095)
      Hum Genet. 1995 Apr;95(4):407-10. (PMID: 7705836)
      PLoS One. 2019 Sep 19;14(9):e0222681. (PMID: 31536563)
      Biochem J. 2003 Aug 15;374(Pt 1):193-8. (PMID: 12775212)
      Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5967-71. (PMID: 20231434)
      N Engl J Med. 1976 Aug 5;295(6):302-4. (PMID: 778616)
      Malar J. 2017 Aug 11;16(1):331. (PMID: 28800732)
      Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20113-8. (PMID: 22123959)
      Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7085-9. (PMID: 1496004)
      Am J Trop Med Hyg. 2006 Oct;75(4):575-81. (PMID: 17038676)
      Science. 1975 Aug 15;189(4202):561-3. (PMID: 1145213)
      CRC Crit Rev Clin Lab Sci. 1975 Mar;5(4):387-412. (PMID: 49254)
      Malar J. 2014 May 03;13:168. (PMID: 24886266)
      Clin Exp Med. 2009 Sep;9(3):249-51. (PMID: 19225719)
      Trans R Soc Trop Med Hyg. 2007 Oct;101(10):1042-4. (PMID: 17604067)
      Nature. 2006 Feb 9;439(7077):741-4. (PMID: 16372020)
    • Accession Number:
      0 (Antigens, Protozoan)
      0 (Duffy Blood-Group System)
      0 (Duffy antigen binding protein, Plasmodium)
      0 (Protozoan Proteins)
      0 (Receptors, Cell Surface)
    • Publication Date:
      Date Created: 20200320 Date Completed: 20200630 Latest Revision: 20210502
    • Publication Date:
      20231215
    • Accession Number:
      PMC7204561
    • Accession Number:
      10.4269/ajtmh.19-0836
    • Accession Number:
      32189613